Guided Anti-P2Y12 Therapy in Patients Undergoing PCI: Three Systematic Reviews with Meta-analyses of Randomized Controlled Trials with Homogeneous Design

The value of guided therapy (GT) with anti-P2Y12 drugs in percutaneous coronary intervention (PCI) is unclear. Meta-analyses lumped together randomized controlled trials (RCTs) with heterogeneous designs, comparing either genotype-GT or platelet function test (PFT)-GT with unguided therapy. Some met...

Full description

Bibliographic Details

Published in:	Thrombosis and haemostasis Vol. 124; no. 5; p. 482
Main Authors:	Birocchi, Simone, Rocchetti, Matteo, Minardi, Alessandro, Podda, Gian Marco, Squizzato, Alessandro, Cattaneo, Marco
Format:	Journal Article
Language:	English
Published:	Germany 01.05.2024
Subjects:	Blood Platelets - drug effects Coronary Artery Disease - therapy Genotype Hemorrhage - chemically induced Humans Percutaneous Coronary Intervention - adverse effects Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Platelet Function Tests Purinergic P2Y Receptor Antagonists - adverse effects Purinergic P2Y Receptor Antagonists - therapeutic use Randomized Controlled Trials as Topic Receptors, Purinergic P2Y12 Treatment Outcome
ISSN:	2567-689X, 2567-689X
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!